These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 11105993)

  • 1. Pranlukast protects leukotriene C4- and D4-induced epithelial cell impairment of the nasal mucosa in vitro.
    Hisamatsu K; Nakajima M
    Life Sci; 2000 Oct; 67(22):2767-73. PubMed ID: 11105993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of leukotriene C4 exposure on ciliated cells of the nasal mucosa.
    Hisamatsu K; Ganbo T; Nakazawa T; Nakajima M; Goto R; Murakami Y
    Prostaglandins; 1996 Jan; 51(1):69-79. PubMed ID: 8900445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukotriene D4-induced mucosal damage during long observation periods in vitro.
    Nakazawa T; Hisamatsu K; Uchida T
    Prostaglandins; 1994 May; 47(5):379-92. PubMed ID: 8066186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of leukotrienes C4 and D4 on ciliary activity of human paranasal sinus mucosa in vitro.
    Ganbo T; Hisamatsu K; Inoue H; Mizukoshi A; Goto R; Murakami Y
    Rhinology; 1995 Dec; 33(4):199-202. PubMed ID: 8919211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pranlukast inhibits NF-kappa B activation in human monocytes/macrophages and T cells.
    Ichiyama T; Hasegawa S; Umeda M; Terai K; Matsubara T; Furukawa S
    Clin Exp Allergy; 2003 Jun; 33(6):802-7. PubMed ID: 12801316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of pranlukast, an oral leukotriene receptor antagonist, on leukotriene D4 (LTD4) challenge in normal volunteers.
    O'Shaughnessy TC; Georgiou P; Howland K; Dennis M; Compton CH; Barnes NC
    Thorax; 1997 Jun; 52(6):519-22. PubMed ID: 9227717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cysteinyl leukotriene upregulates IL-11 expression in allergic airway disease of mice.
    Lee KS; Kim SR; Park HS; Park SJ; Min KH; Lee KY; Jin SM; Lee YC
    J Allergy Clin Immunol; 2007 Jan; 119(1):141-9. PubMed ID: 17208595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of human eosinophil activation by a cysteinyl leukotriene receptor antagonist (pranlukast; ONO-1078).
    Suzuki M; Kato M; Kimura H; Fujiu T; Morikawa A
    J Asthma; 2003 Jun; 40(4):395-404. PubMed ID: 12870835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological differences among CysLT(1) receptor antagonists with respect to LTC(4) and LTD(4) in human lung parenchyma.
    Ravasi S; Capra V; Panigalli T; Rovati GE; Nicosia S
    Biochem Pharmacol; 2002 Apr; 63(8):1537-46. PubMed ID: 11996896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the cysteinyl leukotriene receptor antagonists pranlukast and zafirlukast on tracheal mucus secretion in ovalbumin-sensitized guinea-pigs in vitro.
    Liu YC; Khawaja AM; Rogers DF
    Br J Pharmacol; 1998 Jun; 124(3):563-71. PubMed ID: 9647482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The inhibitory effect of the leukotriene receptor antagonist on leukotriene D4-induced MUC2/5AC gene expression and mucin secretion in human airway epithelial cells.
    Bai CH; Song SY; Kim YD
    Auris Nasus Larynx; 2007 Jun; 34(2):203-6. PubMed ID: 17223000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of a novel leukotriene C4/D4 antagonist, BAY-x-7195, on experimental allergic reactions.
    Tanaka H; Nagai H; Takeda H; Yamaguchi S; Matsuo A; Inagaki N
    Prostaglandins; 1995; 50(5-6):269-85. PubMed ID: 8838238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of new chromanol antagonists of leukotriene D4.
    Chambers RJ; Antognoli GW; Cheng JB; Marfat A; Pillar JS; Shirley JT; Watson JW
    Bioorg Med Chem Lett; 1998 Jul; 8(14):1791-6. PubMed ID: 9873435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pranlukast inhibits NF-kappaB activation and MUC2 gene expression in cultured human epithelial cells.
    Ishinaga H; Takeuchi K; Kishioka C; Suzuki S; Basbaum C; Majima Y
    Pharmacology; 2005 Feb; 73(2):89-96. PubMed ID: 15475658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of pranlukast on histamine release and leukotriene c4 (ltc4) generation from human peripheral basophils].
    Ito R; Miura K; Odajima Y; Shimamura T
    Arerugi; 2004 Jan; 53(1):19-23. PubMed ID: 14762327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CysLT1 receptor antagonists pranlukast and zafirlukast inhibit LRRC8-mediated volume regulated anion channels independently of the receptor.
    Figueroa EE; Kramer M; Strange K; Denton JS
    Am J Physiol Cell Physiol; 2019 Oct; 317(4):C857-C866. PubMed ID: 31390227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Staurosporine inhibits the effects of leukotrienes C4 and D4 in isolated guinea pig heart and trachea.
    Schäfer S; Walland A
    Methods Find Exp Clin Pharmacol; 1995 Sep; 17(7):469-76. PubMed ID: 8577209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cysteinyl leukotriene receptor 1 antagonist pranlukast modulates differentiation of SK-N-SH cells].
    Peng F; Fang SH; Zheng XL; Zhang WP; Lu YB; Wei EQ
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2007 Mar; 36(2):123-8. PubMed ID: 17443897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of ibudilast on ciliary activity of human paranasal sinus mucosa in vitro.
    Ganbo T; Hisamatsu K; Mizukoshi A; Inoue H; Kikushima K; Kou J; Kozuka Y; Murakami Y
    Arzneimittelforschung; 1995 Aug; 45(8):883-6. PubMed ID: 7575753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the cysteinyl leukotriene antagonist pranlukast on transendothelial migration of eosinophils.
    Nagata M; Saito K; Kikuchi I; Hagiwara K; Kanazawa M
    Int Arch Allergy Immunol; 2005; 137 Suppl 1():2-6. PubMed ID: 15947477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.